Oracle Health has introduced new AI features for its Clinical AI Agent in the US that automate professional fee coding, enable real-time dictation into clinical notes, and enhance chart review by highlighting relevant patient information. These tools aim to reduce administrative burdens on clinicians, improve coding accuracy, and streamline workflows, ultimately helping healthcare providers operate more efficiently while maintaining clinician control. Since its launch, the AI agent has saved over 400,000 physician hours, and the new capabilities build on Oracle's expanding AI portfolio in healthcare. The company will showcase these innovations at its upcoming Health and Life Sciences Summit in September 2026.
CoreWeave's stock fell 7% as rising 10-year Treasury yields increased the cost of its significant debt, affecting its valuation despite strong revenue growth and backlog. The company carries a heavy debt load with high interest expenses, making it se...
Oracle and Amazon both reported significant cash flow deficits due to massive investments in AI infrastructure, with Oracle's FY2026 CapEx at $55.66 billion and Amazon's Q2 CapEx at $54.21 billion. Oracle's free cash flow was negative $23.69 billion,...
Steve Eisman, known for his bearish stance before the 2008 housing crash, now highlights a new risk in the AI sector: a potential price war driven by affordable Chinese AI models challenging leaders like OpenAI and Anthropic. While these US-based AI ...
Oracle is rapidly transforming from a legacy database company into a leading cloud hyperscaler, driven by a massive $638 billion backlog in Remaining Performance Obligations (RPO), up 363% year-over-year. The company secured $67 billion in AI infrast...
Bridgewater Associates, led by Ray Dalio, disclosed a $24.4 billion stock portfolio as of June 30, 2026, with a strong focus on ETFs like SPY and IVV, which make up over 25% of holdings. The hedge fund increased its ETF positions but reduced stakes i...
